364 related articles for article (PubMed ID: 32084272)
1. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
[TBL] [Abstract][Full Text] [Related]
2. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.
Sun C; Zhang H; Jiang J; Li Y; Nie C; Gu J; Luo L; Wang Z
Int Ophthalmol; 2020 Feb; 40(2):467-475. PubMed ID: 31802372
[TBL] [Abstract][Full Text] [Related]
4. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.
Funatsu H; Yamashita H; Noma H; Mimura T; Nakamura S; Sakata K; Hori S
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):3-8. PubMed ID: 15258777
[TBL] [Abstract][Full Text] [Related]
5. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
[TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
[TBL] [Abstract][Full Text] [Related]
7. Intraocular tumour necrosis factor ligand related molecule 1 A links disease progression of proliferative diabetic retinopathy after primary vitrectomy.
Wang T; Li J; Xie R; Wang J; Zhang W; Jiang F; Du M; Wang X; Huang B; Brant R; Zhang C; Yan H
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):966-976. PubMed ID: 32064668
[TBL] [Abstract][Full Text] [Related]
8. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
9. Aqueous Humor Analyses in Patients with Diabetic Retinopathy Who Had Undergone Panretinal Photocoagulation.
Kwon JW; Oh J
J Diabetes Res; 2022; 2022():1897344. PubMed ID: 35770197
[TBL] [Abstract][Full Text] [Related]
10. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN
Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
[TBL] [Abstract][Full Text] [Related]
11. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
13. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
Zhang X; Wu J; Wu C; Bian AL; Geng S; Dai RP
Diabetes Res Clin Pract; 2020 Apr; 162():108083. PubMed ID: 32057965
[TBL] [Abstract][Full Text] [Related]
14. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
15. Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous.
Bromberg-White JL; Glazer L; Downer R; Furge K; Boguslawski E; Duesbery NS
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6472-80. PubMed ID: 24003089
[TBL] [Abstract][Full Text] [Related]
16. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
Wu S; He X
Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
[TBL] [Abstract][Full Text] [Related]
17. Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
Urbančič M; Petrovič D; Živin AM; Korošec P; Fležar M; Petrovič MG
Mol Vis; 2020; 26():472-482. PubMed ID: 32606566
[TBL] [Abstract][Full Text] [Related]
18. Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy.
Katome T; Namekata K; Mitamura Y; Semba K; Egawa M; Naito T; Harada C; Harada T
J Diabetes Complications; 2015 Mar; 29(2):275-81. PubMed ID: 25468312
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
